Skip to main content

Next Generation: Sperm-Catching Beads

Sperm-binding, peptide–coated beads work as an implantable contraception device in mice and as a means of selecting human sperm for assisted reproduction techniques, researchers show. 

Written byAnna Azvolinsky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

Green fluorescently tagged sperm, released from epididymis (left), red-tagged sperm after incubation (middle), or mixed (right) binding to the zona pellucida of a mouse oocyte in vitroSCIENCE TRANSLATIONAL MEDICINE, M.A. AVELLA ET AL.The device: Researchers have created peptide-coated agarose beads that bind mouse sperm in vitro and in vivo, as well as human sperm in vitro, according to a study published today (April 27) in Science Translational Medicine. When transplanted into the mouse uterus, the sperm-binding peptide–coated beads prevented fertilization for more than two months, after which the female animal was again fertile.

In vitro, human sperm that reversibly bound to similar peptide–coated beads resembled the male gametes normally selected to have the greatest capacity to bind and fertilize human oocytes.

“You can have anything go wrong in this whole process, but they got it to work and that is surprising and very impressive,” said Deijan Ren, a professor of biology at the University of Pennsylvania in Philadelphia who was not involved in the work.

Mammalian oocytes and preimplantation embryos are coated with a multi-glycoprotein membrane called the zona pellucida. Researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and their colleagues coated inert beads with either mouse or human peptides of one of these glycoproteins, called ZP2, which is required for prefertilization sperm-oocyte ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation